Linagliptin for Patients Aged 70 Years or Older With Type 2 Diabetes Inadequately Controlled With Common Antidiabetes Treatments: A Randomised, Double-Blind, Placebo-Controlled Trial

Study Questions:

What is the safety and efficacy of linagliptin for the treatment of suboptimally controlled diabetes in elderly subjects?